Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.

Autor: Cegielski JP; US Centers for Disease Control and Prevention, Atlanta, Georgia., Kurbatova E; US Centers for Disease Control and Prevention, Atlanta, Georgia., van der Walt M; Medical Research Council, Pretoria, Republic of South Africa., Brand J; Medical Research Council, Pretoria, Republic of South Africa., Ershova J; US Centers for Disease Control and Prevention, Atlanta, Georgia., Tupasi T; Tropical Disease Foundation, Manila, Philippines., Caoili JC; Tropical Disease Foundation, Manila, Philippines., Dalton T; US Centers for Disease Control and Prevention, Atlanta, Georgia., Contreras C; Socios en Salud Sucursal., Yagui M; National Institute of Health, Lima, Peru., Bayona J; Socios en Salud Sucursal., Kvasnovsky C; US Centers for Disease Control and Prevention, Atlanta, Georgia., Leimane V; Riga East University Hospital Centre of Tuberculosis and Lung Diseases, Latvia., Kuksa L; Riga East University Hospital Centre of Tuberculosis and Lung Diseases, Latvia., Chen MP; US Centers for Disease Control and Prevention, Atlanta, Georgia., Via LE; National Institute for Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland., Hwang SH; National Masan Hospital, Changwon., Wolfgang M; US Centers for Disease Control and Prevention, Atlanta, Georgia., Volchenkov GV; Vladimir Oblast Tuberculosis Dispensary., Somova T; Vladimir Oblast Tuberculosis Dispensary., Smith SE; US Centers for Disease Control and Prevention, Atlanta, Georgia., Akksilp S; Ministry of Health, Bangkok., Wattanaamornkiet W; Office of Disease Prevention and Control Region 7, Ubon Ratchathani, Thailand., Kim HJ; Korean Institute of Tuberculosis, Seoul, Republic of Korea., Kim CK; Korean Institute of Tuberculosis, Seoul, Republic of Korea., Kazennyy BY; Orel Oblast Tuberculosis Dispensary., Khorosheva T; Orel Oblast Tuberculosis Dispensary., Kliiman K; Tartu University Hospital., Viiklepp P; National Tuberculosis Registry, National Institute for Health Development,Tallinn, Estonia., Jou R; Taiwan Centers for Disease Control, Taipei., Huang AS; Taiwan Centers for Disease Control, Taipei., Vasilyeva IA; Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow, Russian Federation., Demikhova OV; Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow, Russian Federation., Lancaster J, Odendaal R, Diem L, Perez TC, Gler T, Tan K, Bonilla C, Jave O, Asencios L, Yale G, Suarez C, Walker AT, Norvaisha I, Skenders G, Sture I, Riekstina V, Cirule A, Sigman E, Cho SN, Cai Y, Eum S, Lee J, Park S, Jeon D, Shamputa IC, Metchock B, Kuznetsova T, Akksilp R, Sitti W, Inyapong J, Kiryanova EV, Degtyareva I, Nemtsova ES, Levina K, Danilovits M, Kummik T, Lei YC, Huang WL, Erokhin VV, Chernousova LN, Andreevskaya SN, Larionova EE, Smirnova TG

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2016 Feb 15; Vol. 62 (4), pp. 418-430. Date of Electronic Publication: 2015 Oct 27.

Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.

Autor: Cegielski JP; Centers for Disease Control and Prevention, Atlanta, Georgia., Dalton T; Centers for Disease Control and Prevention, Atlanta, Georgia., Yagui M; National Institute of Health, Lima, Peru., Wattanaamornkiet W; Department of Disease Control, Ministry of Public Health, Bangkok, Thailand., Volchenkov GV; Vladimir Oblast Tuberculosis Dispensary, Russian Federation., Via LE; National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Van Der Walt M; Medical Research Council, Pretoria, Republic of South Africa., Tupasi T; Tropical Disease Foundation, Manila, Republic of the Philippines., Smith SE; Centers for Disease Control and Prevention, Atlanta, Georgia., Odendaal R; Medical Research Council, Pretoria, Republic of South Africa., Leimane V; Riga East University Hospital Centre of Tuberculosis and Lung Diseases, Latvia., Kvasnovsky C; Centers for Disease Control and Prevention, Atlanta, Georgia., Kuznetsova T; Vladimir Oblast Tuberculosis Dispensary, Russian Federation., Kurbatova E; Centers for Disease Control and Prevention, Atlanta, Georgia., Kummik T; Tartu University Hospital, Estonia., Kuksa L; Riga East University Hospital Centre of Tuberculosis and Lung Diseases, Latvia., Kliiman K; Tartu University Hospital, Estonia., Kiryanova EV; Orel Oblast Tuberculosis Dispensary, Russian Federation., Kim H; Korean Institute of Tuberculosis, Seoul, Republic of Korea., Kim CK; Korean Institute of Tuberculosis, Seoul, Republic of Korea., Kazennyy BY; Orel Oblast Tuberculosis Dispensary, Russian Federation., Jou R; Taiwan Centers for Disease Control, Taipei., Huang WL; Taiwan Centers for Disease Control, Taipei., Ershova J; Centers for Disease Control and Prevention, Atlanta, Georgia., Erokhin VV; Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow., Diem L; Centers for Disease Control and Prevention, Atlanta, Georgia., Contreras C; Socios en Salud Sucursal, Lima, Peru., Cho SN; International Tuberculosis Research Center, Changwon Yonsei University College of Medicine, Seoul, Republic of Korea., Chernousova LN; Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow., Chen MP; Centers for Disease Control and Prevention, Atlanta, Georgia., Caoili JC; Tropical Disease Foundation, Manila, Republic of the Philippines., Bayona J; Socios en Salud Sucursal, Lima, Peru., Akksilp S; Department of Disease Control, Ministry of Public Health, Bangkok, Thailand.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2014 Oct 15; Vol. 59 (8), pp. 1049-63. Date of Electronic Publication: 2014 Jul 23.

A case report of persistent drug-sensitive pulmonary tuberculosis after treatment completion.

Autor: Vashakidze, Sergo A.^1,2 (AUTHOR) sergovashakidze@yahoo.com, Chandrakumaran, Abivarma³ (AUTHOR), Japaridze, Merab¹ (AUTHOR), Gogishvili, Giorgi¹ (AUTHOR), Collins, Jeffrey M.⁴ (AUTHOR), Rekhviashvili, Manana¹ (AUTHOR), Kempker, Russell R.⁴ (AUTHOR)

Publikováno v: BMC Infectious Diseases. 11/19/2022, Issue 1, p1-8. 8p.

Pharmacokinetics and Safety of Group A and B Anti-Tuberculosis Drugs Used in Treatment of Rifampicin-Resistant Tuberculosis during Pregnancy and Post-Partum: A Narrative Review.

Autor: Hughes, Jennifer

Publikováno v: Pathogens; Dec2023, Vol. 12 Issue 12, p1385, 12p

Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis using machine learning methods.

Autor: You, Shiying, Chitwood, Melanie H., Gunasekera, Kenneth S., Crudu, Valeriu, Codreanu, Alexandru, Ciobanu, Nelly, Furin, Jennifer, Cohen, Ted, Warren, Joshua L., Yaesoubi, Reza

Publikováno v: PLoS Digital Health; 6/30/2022, Vol. 1 Issue 6, p1-18, 18p